ArticleFrontiers in neuroscience2026
Glymphatic dysfunction and cognitive impairment in tuberculous meningitis: insights from diffusion tensor imaging along the perivascular space (DTI-ALPS).
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculous meningitis (TBM), a severe central nervous system infection, carries significant mortality and long-term neurological morbidity. While cognitive impairment is a common consequences of TBM, the contribution of glymphatic system dysfunction to this process remains poorly characterized. Objective: To investigate glymphatic function in TBM patients using the diffusion tensor imaging (DTI)-derived along the perivascular space (ALPS) index and evaluate its utility in detecting and predicting mild cognitive impairment (MCI). Methods: This cross-sectional study enrolled 62 TBM patients and 61 matched healthy controls (HCs). ALPS indices (left/right/whole-brain) were computed from DTI data. Cognitive function was assessed using MMSE, MoCA, TMT-A/B, CDT, VFT, DST, and SDMT. Group comparisons, partial correlation analyses, and ROC curve assessments were performed to examine relationships between glymphatic function and cognitive performance. Results: TBM patients demonstrated significantly reduced ALPS indices (all Conclusion: The DTI-ALPS index effectively captures glymphatic dysfunction in TBM and correlates with domain-specific cognitive deficits. As a non-invasive biomarker, it shows promise for early identification of TBM patients at risk for MCI, potentially facilitating timely intervention to mitigate cognitive decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.